Key facts
- Notable investors include Fuyang Yingke Fund Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ruihua Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Ruihua Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ruihua Pharmaceutical
Operator of a pharmaceutical manufacturing company intended to research, develop, produce, and sell pharmaceutical intermediates, fine chemicals, and biotechnology products. The company offers a diverse product portfolio, including recombinant proteins, enzymes, bioactive peptides, amino acids, alcohols, ketones, and esters, enabling pharmaceutical, food, cosmetics, and daily chemical industries to enhance product quality and meet specific application needs.
- Sector
- Healthcare
- HQ
- Fuyang, China
- Founded
- 2018
- Employees
- 2
- Ownership
- Privately Held (backing)
Ruihua Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ruihua Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ruihua Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.